NPPA~India🇮🇳

The Government remains fully engaged in facilitating supplies on a case-by-case basis, with active support from the Ministry of Petroleum and Natural Gas, to ensure uninterrupted production of essential medicines : Shri Satyaprakash T L, Joint Secretary, Department of Pharmaceuticals @PIB_India @PIBHindi @DDNewslive @mygovindia @airnewsalerts #EnergySecurity

I am happy to share that the Department of Pharmaceuticals, along with FICCI and the Indian Pharmaceutical Alliance, is organising the 9th edition of India Pharma 2026 With the theme ‘Discovering India, Leapfrogging Life Science Innovation’, the event highlights India’s journey from the pharmacy of the world to a global leader in pharma innovation and research. Join us in shaping the future of healthcare - From India, For the World : Shri Awadhesh Kumar Choudhary, Economic Advisor, Department of Pharmaceuticals @IndiaPharma2026 @PIB_India @mygovindia #IndiaPharma2026 #PharmaInnovation #LifeSciences #HealthcareIndia

Biopharma Shakti marks a tipping point for biologics and biosimilars innovation in India. India Pharma 2026, brings together all stakeholders, industry, scientists and CEOs to drive collaboration across finance, governance and R&D : Shri Satyaprakash T L, Joint Secretary, Department of Pharmaceuticals @PIB_India @PIBHindi @mygovindia @IndiaPharma2026 #IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

Department of Pharmaceuticals, Government of India, in collaboration with FICCI and Indian Pharmaceutical Alliance, is organizing the 9th edition of India Pharma on 13-14 April at FICCI Federation House. With the theme 'Discover in India : Leapfrogging Life Sciences Innovation,' the summit reflects India’s important transition from manufacturing generic drugs to advancing innovative drug development. The recently announced Bio Pharma Shakti mission in the Union Budget further strengthens this vision-creating significant opportunities for innovators, researchers, and industry stakeholders to come together and shape India’s journey towards becoming a global powerhouse in biopharmaceuticals and drug discovery : Shri Aman Sharma, Joint Secretary, Department of Pharmaceuticals @IndiaPharma2026 @PIB_India @PIBHindi @mygovindia #IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

6 days to go until India Pharma 2026 brings together the brightest minds in policy, science, and industry under one roof. Be part of the conversations shaping the next era of pharmaceuticals and life sciences in India and beyond. The 9th edition of India Pharma 2026 is being organised by the Department of Pharmaceuticals, Government of India, in association with FICCI and the Indian Pharmaceutical Alliance (IPA). Register Here : meet.ficci.in/invitee-form.a… 📅 13th & 14th April 2026 📍 FICCI Federation House, New Delhi #IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

As part of the ongoing Sādhana Saptah 2026, the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Government of India, organised a webinar today on “AI and Emerging Technologies in Pharmaceuticals and Regulations”. The webinar highlighted the transformative potential of Artificial Intelligence (AI) across the pharmaceutical value chain, spanning drug discovery, development, and regulatory science. The session was addressed by Prof. Manoj Kumar, Professor, Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Mohali. Officers and staff of the Department actively participated in the session. Read Here : pib.gov.in/PressReleasePa… @DoPTGoI @PIB_India @PIBHindi @mygovindia #SādhanaSaptah #SādhanaSaptah2026 #MissionKarmayogi #हमबनेंकर्मयोगी #CapacityBuilding #WeBecomeKarmayogi

The Government of India has announced a significant decision to bring several critical petrochemical products under zero import duty. Amid global disruptions and supply chain challenges, this move provides substantial relief to the pharmaceutical sector by helping stabilize prices and supporting manufacturers, solvent suppliers, and end consumers. It is a timely and forward-looking step aimed at strengthening supply chains and ensuring market stability: Namit Joshi, Chairman, Pharmexil #Pharmaceuticals #PolicyUpdate #IndustryRelief

Pharma this month From Jan Aushadhi Saptah to PharmaMed 2026. #Pharmathismonth #Pharmaceuticals

Just 15 days to go! The 9th edition of India Pharma 2026 will bring together policymakers, industry leaders, innovators, and global stakeholders to shape the future of pharma and life sciences, organised by the Department of Pharmaceuticals in association with FICCI and Indian Pharmaceutical Alliance. Registration Link: lnkd.in/g2hVTaNz Date : 13th & 14th April 2026 Venue : FICCI Federation House, New Delhi #IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

As part of strengthening academia-industry collaboration and knowledge exchange, National Institute of Pharmaceutical Education and Research (NIPERs) have signed 356 Memoranda of Understanding (MoUs) with leading industries and academic institutions, research excellence and skill development across the pharmaceutical and medical devices sector. #NIPER #MoU #PharmaInnovation #AcademiaIndustry

RT @Pharmadept: The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers in association with the PHD Chamber of C…

#Gujarat #PMRU

National Institute of Pharmaceutical Education and Research (NIPERs) offer postgraduate programs such as MS (Pharm), M. Tech (Pharm), MBA, Integrated PhD and PhD, along with advanced research in pharmaceutical sciences across areas such as Pharmacology, Biotechnology, Pharmaceutics, and Medical Technology. They conduct high-end research in pharma and medical technology with strong industry-academia linkages. Admissions to these programs across all 7 NIPERs are through a common JEE held annually (June/July), open to candidates qualified in Graduate Pharmacy Aptitude Test. #NIPER

20 days left until India Pharma 2026 brings together the brightest minds in policy, science, and industry under one roof. Be part of the conversations shaping the next era of pharmaceuticals and life sciences in India and beyond. The 9th edition of India Pharma 2026 is being organised by the Department of Pharmaceuticals, Government of India, in association with FICCI and the Indian Pharmaceutical Alliance (IPA). Secure your spot today at: meet.ficci.in/invitee-form.a… Interested companies are requested to share their profile at: lifesciences@ficci.com 📅 13th & 14th April 2026 📍 FICCI Federation House, New Delhi #IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

Explore the twenty-seventh issue of NPPA 's bi-monthly e-newsletter- #AUSHADH_SANDESH, on drug price regulation, policy updates, and initiatives. Read now English version: nppa.gov.in/uploads/librar… #NPPA #AffordableMedicine

With National Institute of Pharmaceutical Education and Research (NIPER) across the country securing positions in the Top 30 of the National Institutional Ranking Framework (NIRF) 2025, India continues to strengthen pharmaceutical education and research.🎓 From Hyderabad to Hajipur, these institutes are nurturing innovation, advancing drug discovery, and building the next generation of pharma leaders. #NIPER #Pharmaceuticals

India’s pharmaceutical industry stands as a global leader in generic drugs while advancing in biosimilars, complex generics, and specialty drugs through strengthened R&D. To support this growth, 7 National Institutes of Pharmaceutical Education & Research (NIPERs) are nurturing a strong talent base in drug discovery and development.💊 #NIPER #Pharmaceuticals

#Odisha #PMRU delivered an insightful session on “Affordable Medicines for All”, highlighting the importance of accessibility and awareness of cost-effective medicines. Additionally, installation and awareness of the #Pharma_Sahi_Daam app

@NIPERRaebareli and @Roche Pharma India sign an MoU to foster academic–industry collaboration and strengthen pharmaceutical education and research in India by building skills & capabilities for innovation and regulatory practices @Pharmadept #ViksitBharat2040 #BiopharmaShakti

A webinar to mark the second anniversary of the India–EFTA Trade and Economic Partnership Agreement (TEPA) was organised by the Department of Pharmaceuticals. Representatives from Export Promotion Councils, industry associations, and Pharma & Medical devices sectors participated. Discussion focused on strengthening collaboration through investment, technology transfer (ToT), joint technology development, and enhanced B2B engagements, while exploring ways to deepen India–EFTA cooperation in pharmaceuticals and medical devices sector. #IndiaEFTATEPA